LTGO (Latigo Biotherapeutics) FCF Margin %: 0.00% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTGO Latigo Biotherapeutics Inc LTGO
8 GF Score
Price $18.56
View Full Analysis

What is Latigo Biotherapeutics FCF Margin %?

Latigo Biotherapeutics LTGO +1.70% 8 FCF Margin % is 0.00% as of Dec. 2025. GuruFocus rates LTGO with a GF Score™ of 8/100. Among 953 Biotechnology companies, Latigo Biotherapeutics ranks worse than 104931.69% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Latigo Biotherapeutics's Free Cash Flow for the six months ended in Dec. 2025 was $-97.69 Mil. Latigo Biotherapeutics's Revenue for the six months ended in Dec. 2025 was $0.00 Mil. Therefore, Latigo Biotherapeutics's FCF Margin % for the quarter that ended in Dec. 2025 was 0.00%.

As of today, Latigo Biotherapeutics's current FCF Yield % is -320,800.00%.

The historical rank and industry rank for Latigo Biotherapeutics's FCF Margin % or its related term are showing as below:


LTGO's FCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -77.94
* Ranked among companies with meaningful FCF Margin % only.

Latigo Biotherapeutics FCF Margin % Related Terms

Latigo Biotherapeutics FCF Margin % Historical Data

* Premium members only.

The historical data trend for Latigo Biotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Latigo Biotherapeutics FCF Margin % Chart

Latigo Biotherapeutics Annual Data
Trend Dec24 Dec25
FCF Margin %
0.00 0.00

Latigo Biotherapeutics Semi-Annual Data
Dec24 Dec25
FCF Margin % 0.00 0.00

LTGO vs : FCF Margin % Comparison

For the Biotechnology subindustry, Latigo Biotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Latigo Biotherapeutics FCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Latigo Biotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Latigo Biotherapeutics's FCF Margin % falls into.


LTGO
8GF Score
Latigo Biotherapeutics Inc LTGO
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Latigo Biotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Latigo Biotherapeutics's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-97.693/0
= %

Latigo Biotherapeutics's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-97.693/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of 0.00% mean?
Latigo Biotherapeutics (LTGO) has a FCF Margin % of 0.00% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Latigo Biotherapeutics and its competitors. According to the industry distribution chart, Latigo Biotherapeutics ranks #999999 out of 953 companies in the Biotechnology industry.
Is Latigo Biotherapeutics' FCF Margin % too high?
Latigo Biotherapeutics' current FCF Margin % is 0.00%. Based on the distribution chart, Latigo Biotherapeutics ranks #999999 out of 953 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Latigo Biotherapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Latigo Biotherapeutics' FCF Margin % compare to ?
According to the Biotechnology industry distribution chart, Latigo Biotherapeutics ranks #999999 out of 953 companies for FCF Margin %. This places Latigo Biotherapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Biotechnology company?
A good FCF Margin % depends on the Biotechnology industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Latigo Biotherapeutics and its competitors. Latigo Biotherapeutics's current FCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Latigo Biotherapeutics stock overvalued right now?
Latigo Biotherapeutics (LTGO) has a current FCF Margin % of 0.00%. The current FCF Margin % is 0.00%. Latigo Biotherapeutics' overall GF Score™ is 8/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Latigo Biotherapeutics (LTGO), the current FCF Margin % is 0.00% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Latigo Biotherapeutics Business Description

Comparable Companies
Address 1300 Rancho Conejo Boulevard, Suite 305, Thousand Oaks, CA, USA, 91320
Latigo Biotherapeutics Inc is a clinical-stage biotechnology company focused on developing non-opioid pain medicines designed to rapidly and effectively stop the transmission of pain without the risk of addiction. Its flagship product candidates, LTG-001 and LTG-321, are oral Nav1.8 inhibitors being developed for the treatment of acute pain. The company is also developing additional Nav1.8 inhibitor candidates using alternative formulations and delivery approaches.
8GF Score

Get the complete analysis for LTGO

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$18.56
Price